NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
Back to search
Official data from USPTO
PHARMACY ON DEMAND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMACY ON DEMAND
ST13
US500000098366199Class
40
Filing
98366199
Registration
7837436
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/17/2025
Trademark type
Word
Nice classes
40
Filing date
01/19/2024
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
06/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
09/19/2024
First use in commerce
09/19/2024
Drawing code
4
Owner type
03
Owner location
Rockville, MD, US
Examiner
DIBBLE,JENNA M
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
On Demand Pharmaceuticals, Inc.
Representatives
Daniel P. Mullarkey Polsinelli PC
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacturing of pharmaceuticals for others
Publications
History of USPTO decisions and trademark events.
25 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/17/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/14/2025
IUAA
USE AMENDMENT ACCEPTED
05/14/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/09/2025
IUAF
USE AMENDMENT FILED
05/09/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/09/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/24/2025
GNRT
NON-FINAL ACTION E-MAILED
02/24/2025
CNRT
NON-FINAL ACTION WRITTEN
02/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/30/2025
ALIE
ASSIGNED TO LIE
01/30/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2025
NREV
NOTICE OF REVIVAL - E-MAILED
01/24/2025
PETG
PETITION TO REVIVE-GRANTED
01/24/2025
PROA
TEAS PETITION TO REVIVE RECEIVED
01/24/2025
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
12/02/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
12/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/14/2024
GNRT
NON-FINAL ACTION E-MAILED
08/14/2024
CNRT
NON-FINAL ACTION WRITTEN
08/14/2024
DOCK
ASSIGNED TO EXAMINER
08/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/21/2024
NWAP
NEW APPLICATION ENTERED
01/19/2024
Continuous trademark protection
Get notified about every new filing that threatens PHARMACY ON DEMAND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.